Northwestern Mutual Wealth Management’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $62 | Hold |
48
| – | – | ﹤0.01% | 4016 |
|
|
2026
Q1 | $78 | Sell |
48
-4
| -8% | -$8 | ﹤0.01% | 4012 |
|
|
2025
Q4 | $146 | Buy |
52
+4
| +8% | +$9 | ﹤0.01% | 3824 |
|
|
2025
Q3 | $99 | Hold |
48
| – | – | ﹤0.01% | 3713 |
|
|
2025
Q2 | $151 | Hold |
48
| – | – | ﹤0.01% | 3530 |
|
|
2025
Q1 | $151 | Sell |
48
-60
| -56% | -$237 | ﹤0.01% | 3477 |
|
|
2024
Q4 | $468 | Buy |
108
+60
| +125% | +$188 | ﹤0.01% | 3391 |
|
|
2024
Q3 | $128 | Hold |
48
| – | – | ﹤0.01% | 3474 |
|
|
2024
Q2 | $107 | Hold |
48
| – | – | ﹤0.01% | 3387 |
|
|
2024
Q1 | $256 | Hold |
48
| – | – | ﹤0.01% | 3377 |
|
|
2023
Q4 | $71 | Hold |
48
| – | – | ﹤0.01% | 3391 |
|
|
2023
Q3 | $67 | Hold |
48
| – | – | ﹤0.01% | 3215 |
|
|
2023
Q2 | $71 | Hold |
48
| – | – | ﹤0.01% | 3278 |
|
|
2023
Q1 | $79 | Hold |
48
| – | – | ﹤0.01% | 3261 |
|
|
2022
Q4 | $67 | Hold |
48
| – | – | ﹤0.01% | 3238 |
|
|
2022
Q3 | $0 | Hold |
48
| – | – | ﹤0.01% | 3165 |
|
|
2022
Q2 | $0 | Hold |
48
| – | – | ﹤0.01% | 3220 |
|
|
2022
Q1 | $0 | Hold |
48
| – | – | ﹤0.01% | 3151 |
|
|
2021
Q4 | $0 | Hold |
48
| – | – | ﹤0.01% | 3165 |
|
|
2021
Q3 | $0 | Hold |
48
| – | – | ﹤0.01% | 3042 |
|
|
2021
Q2 | $0 | Hold |
48
| – | – | ﹤0.01% | 3029 |
|
|
2021
Q1 | $0 | Hold |
48
| – | – | ﹤0.01% | 2795 |
|
|
2020
Q4 | $1K | Hold |
48
| – | – | ﹤0.01% | 2596 |
|
|
2020
Q3 | $1K | Hold |
48
| – | – | ﹤0.01% | 2427 |
|
|
2020
Q2 | $0 | Sell |
48
-7,084
| -99% | -$14.5K | ﹤0.01% | 2436 |
|
|
2020
Q1 | $7K | Buy |
7,132
+7,084
| +14,758% | +$10K | ﹤0.01% | 1976 |
|
|
2019
Q4 | $0 | Hold |
48
| – | – | ﹤0.01% | 2419 |
|
|
2019
Q3 | $0 | Hold |
48
| – | – | ﹤0.01% | 2488 |
|
|
2019
Q2 | $0 | Hold |
48
| – | – | ﹤0.01% | 2531 |
|
|
2019
Q1 | $0 | Buy |
48
+1
| +2% | +$4 | ﹤0.01% | 2549 |
|
|
2018
Q4 | $0 | Hold |
47
| – | – | ﹤0.01% | 2425 |
|
|
2018
Q3 | $0 | Hold |
47
| – | – | ﹤0.01% | 2484 |
|
|
2018
Q2 | $0 | Hold |
47
| – | – | ﹤0.01% | 2381 |
|
|
2018
Q1 | $1K | Hold |
47
| – | – | ﹤0.01% | 2096 |
|
|
2017
Q4 | $1K | Hold |
47
| – | – | ﹤0.01% | 2203 |
|
|
2017
Q3 | $2K | Hold |
47
| – | – | ﹤0.01% | 1958 |
|
|
2017
Q2 | $4K | Hold |
47
| – | – | ﹤0.01% | 1776 |
|
|
2017
Q1 | $4K | Hold |
47
| – | – | ﹤0.01% | 1744 |
|
|
2016
Q4 | $7K | Buy |
+47
| New | +$11K | ﹤0.01% | 1725 |
|
Other funds holding CRDF
LCM
P
Northwestern Mutual Wealth Management's CRDF Position: Q2 2026 in Review
Northwestern Mutual Wealth Management held its Cardiff Oncology (CRDF) position steady in Q2 2026 at 48 shares worth $62. The position accounts for ﹤0.01% of the portfolio, ranked #4016.
Northwestern Mutual Wealth Management first reported a position in CRDF in Q4 2016 and has held it in 39 quarters since. The position peaked at $7K in Q1 2020. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.
- Northwestern Mutual Wealth Management held 48 shares of Cardiff Oncology worth $62 as of Q2 2026.
- Northwestern Mutual Wealth Management left its Cardiff Oncology share count unchanged in Q2 2026.
- Cardiff Oncology made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #4016 holding.
- Northwestern Mutual Wealth Management first reported a position in Cardiff Oncology in Q4 2016 and has held it in 39 quarters since.
- Northwestern Mutual Wealth Management's Cardiff Oncology position peaked at $7K in Q1 2020.
- 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.